Evidence map›Paper›PMID 37451710›Full record

ArticleBMJ open2023

SuPreme Study: a protocol to study the neuroprotective potential of sulfate among very/extremely preterm infants.

Elizabeth M Hurrion, Nadia Badawi, Roslyn N Boyd, Catherine Morgan, Kristen Gibbons, Stefanie Hennig, Pieter Koorts, Manbir Chauhan, Francis Bowling, Vicki Flenady and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Sulfation pathways in times of change.Essays in biochemistry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Elizabeth M HurrionDepartment of Newborn Services, Mater Mothers' Hospital, Brisbane, Queensland, Australia elizabeth.hurrion@mater.org.au.ORCID 0000-0002-3950-8907
Nadia BadawiCerebral Palsy Alliance, The University of Sydney, Sydney, New South Wales, Australia.
Roslyn N BoydQueensland Cerebral Palsy and Rehabilitation Research Centre, The University of Queensland, Saint Lucia, Queensland, Australia.
Catherine MorganCerebral Palsy Alliance, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-3670-0845
Kristen GibbonsChild Health Research Centre, Mater Research Institute The University of Queensland, South Brisbane, Queensland, Australia.
Stefanie HennigSchool of Clinical Sciences, Queensland University of Technology Faculty of Health, Kelvin Grove, Queensland, Australia.
Pieter KoortsGrantley Stable Neonatal Unit, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
Manbir ChauhanDepartment of Newborn Care, Gold Coast University Hospital, Southport, Queensland, Australia.
Francis BowlingWalter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
Vicki FlenadyMater Research Institute The University of Queensland, South Brisbane, Queensland, Australia.
Sailesh KumarMater Research Institute The University of Queensland, South Brisbane, Queensland, Australia.ORCID 0000-0003-0832-4811
Paul A DawsonMater Research Institute The University of Queensland, South Brisbane, Queensland, Australia.ORCID 0000-0002-7318-4985
The University of Queensland · AUThe University of Sydney · AUGold Coast Hospital · AUQueensland University of Technology · AURoyal Brisbane and Women's Hospital · AUUnited Cerebral Palsy · USWalter and Eliza Hall Institute of Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAntenatal maternal magnesium sulfate (MgSO METHODS AND ANALYSIS: This is a prospective observational cohort study, in three tertiary Australian centres. Participants are preterm infants, irrespective of antenatal MgSO ETHICS AND DISSEMINATION: The study has been approved by Mater Misericordiae Ltd Human Research Ethics Committee (HREC/14/MHS/188). Results will be disseminated in peer-reviewed journal publications, and provided to the funding bodies. Using consumer input, a summary will be prepared for participants and consumer groups.

Indexed as

Cerebral PalsyInfant, Premature, DiseasesNeuroprotective AgentsPremature BirthAustraliaCohort StudiesFemaleFetal Growth RetardationHumansInfantInfant, Extremely PrematureInfant, NewbornMagnesiumObservational Studies as TopicPregnancySulfatesMagnesiumNeuroprotective AgentsSulfatesDevelopmental neurology & neurodisabilityNEONATOLOGYPaediatric neurology

Identifiers

PMID37451710
PMCPMC10351292
OpenAlexW4384344095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.